Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded
- Contract number
- SPE2DR26F3DV8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,051
Award facts
- Contract value 100% obligated
- $19,051.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $19,051.10 to supply Dupixent 300 mg/2 ml syringes on a firm fixed price basis. This non-set-aside award was issued on November 18, 2025, with an ultimate completion date of November 19, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic immunosuppressant used to treat conditions including atopic dermatitis, asthma, and chronic rhinosinusitis, making it a critical pharmaceutical product for military healthcare needs.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and established federal vendor, AmerisourceBergen serves as a prime vendor for the Defense Health Agency and other government healthcare systems, supplying a comprehensive range of brand-name and generic medications, specialty pharmaceuticals, and medical supplies to support military healthcare programs globally. The company's extensive federal contract portfolio demonstrates its consistent capability to meet competitive procurement requirements and fulfill critical medical supply needs across the military healthcare system.
Quick answers
Who was awarded contract SPE2DR26F3DV8?
SPE2DR26F3DV8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 18, 2025.
How much is contract SPE2DR26F3DV8 worth?
The government has obligated $19,051 on SPE2DR26F3DV8.
Is contract SPE2DR26F3DV8 an order under another contract?
Yes. SPE2DR26F3DV8 is a delivery order under SPE2DR25D3017, an indefinite delivery contract.
Was contract SPE2DR26F3DV8 competed?
The extent of competition for SPE2DR26F3DV8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award